A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the
treatment of bleeding episodes in hemophilia A or B patients with inhibitors.